Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia

Archives of Dermatology

Volumn 142, Issue 1, 2006, Pages 75-78

  Browning, Catherine E ^a   Callen, Jeffrey P ^a,b  

^a University of Louisville School of Medicine   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; HYDROXYCHLOROQUINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOXIFYLLINE; PREDNISONE; STANOZOLOL; WARFARIN;

ADULT; ANAMNESIS; ANTICOAGULATION; ARTICLE; CASE REPORT; CLINICAL FEATURE; DOPPLER ECHOGRAPHY; FIBRINOGEN BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERHOMOCYSTEINEMIA; LABORATORY TEST; LIVEDO RETICULARIS; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SEXUAL DYSFUNCTION; THORAX RADIOGRAPHY;

ANTICOAGULANTS; BIOPSY; CRYOGLOBULINEMIA; CRYOGLOBULINS; DIAGNOSIS, DIFFERENTIAL; FIBRINOGENS, ABNORMAL; FOLLOW-UP STUDIES; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; SKIN; SKIN DISEASES, VASCULAR; WARFARIN;

EID: 30844459019     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.142.1.75     Document Type: Article

References (28)

1. Bard JW, Winkelmann RK. Livedo vasculitis: segmental hyalinizing vasculitis of the dermis. Arch Dermatol. 1967;96:489-499.
2. Jorizzo JL. Livedoid vasculopathy: what is it? Arch Dermatol. 1998;134:491-493.
3. Papi M, Didona B, De Pitá O, et al. Livedo vasculopathy vs small vessel cutaneous vasculitis: cytokine and platelet P-selectin studies. Arch Dermatol. 1998;134:447-451.
4. Shornick JK, Nicholes BK, Bergstresser PR, Gilliam JN. Idiopathic atrophie blanche. J Am Acad Dermatol. 1983;8:792-798.
5. Maessen-Visch MB, Koedam MI, Hamulyák K, Neumann HA. Atrophie blanche. Int J Dermatol. 1999;38:161-172.
6. Margolis DJ, Kruithof EKO, Barnard M, Howe K, Lazarus GS. Fibrinolytic abnormalities abnormalities in two different cutaneous manifestations of venous disease. J Am Acad Dermatol. 1996;34:204-208.
7. Acland KM, Darvay A, Wakelin SH, Russell-Jones R. Livedoid vasculitis: a manifestation of the antiphospholipid syndrome? Br J Dermatol. 1999;140:131-135.
8. Winkelmann RK, Schroeter AL, Kierland RR, Ryan TM. Clinical studies of livedoid vasculitis (segmental hyalinizing vasculitis). Mayo Clin Proc. 1974;49:746-750.
9. Calamia KT, Balabanova M, Perniciaro C, Walsh JS. Livedo (livedoid) vasculitis and the factor V Leiden mutation: additional evidence for abnormal coagulation. J Am Acad Dermatol. 2002;46:133-137.
10. Drucker CR, Duncan WC. Antiplatelet therapy in atrophie blanche and livedo vasculitis. J Am Acad Dermatol. 1982;7:359-363.
11. McCalmont CS, McCalmont TH, Jorizzo JL, White WL, Leshin B, Rothberger H. Livedo vasculitis: vasculitis or thrombotic vasculopathy? Clin Exp Dermatol. 1992;17:4-8.
12. Edirisinghe SP. Homocysteine-induced thrombosis. Br J Biomed Sci. 2004;61:40-47.
13. Ball GV, Goldman LN. Chronic ulcerative colitis, skin necrosis, and cryofibrinogenemia. Ann Intern Med. 1976;85:464-466.
14. Cohen SJ, Pittelkow MR, Su WP. Cutaneous manifestations of cryoglobulinemia: clinical and histopathologic study of seventy-two patients. J Am Acad Dermatol. 1991;25:21-27.
15. Ferri C, Zignego AL, Pileri SA. Cryoglobulins. J Clin Pathol. 2002;55:4-13.
16. Blain H, Cacoub P, Musset L, et al. Cryofibrinogenaemia: a study of 49 patients. Clin Exp Immunol. 2000;120:253-260.
17. Heine KG, Davis GW. Idiopathic atrophie blanche: treatment with low-dose heparin. Arch Dermatol. 1986;122:855-856.
18. Sauer GC. Pentoxifylline (Trental) therapy for the vasculitis of atrophie blanche. Arch Dermatol. 1986;122:380-381.
19. Lee SS, Ang P, Tan SH. Clinical profile and treatment outcome of livedoid vasculitis: a case series. Ann Acad Med Singapore. 2003;32:835-839.
20. Hsiao GH, Chiu HC. Livedoid vasculitis: response to low-dose danazol. Arch Dermatol. 1996;132:749-751.
21. Klein KL, Pittelkow MR. Tissue plasminogen activator for treatment of livedoid vasculitis. Mayo Clin Proc. 1992;67:923-933.
22. Purcell SM, Hayes TJ. Nifedipine treatment of idiopathic atrophie blanche. J Am Acad Dermatol. 1986;14:851-854.
23. Bisalbutra P, Kullavanijaya P. Sulfasalazine in atrophie blanche. J Am Acad Dermatol. 1993;28:275-276.
24. Rustin MHA, Bunker CB, Dowd PM. Chronic leg ulceration with livedoid vasculitis, and response to oral ketanserin. Br J Dermatol. 1989;120:101-105.
25. Ravat FE, Evans AV, Russell-Jones R. Response of livedoid vasculitis to intravenous immunoglobulin. Br J Dermatol. 2002;147:166-169.
26. Lee JH, Choi HJ, Kim SM, Hann SK, Park YK. Livedoid vasculitis responding to PUVA therapy. Int J Dermatol. 2001;40:153-157.
27. Francès C, Barete S. Difficult management of livedoid vasculopathy. Arch Dermatol. 2004;140:1011.
28. Hirsh J, Dalen JE, Anderson DR, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 2001;119(suppl):8S-21S.